Dr. Kutlar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-2505Fax+1 706-721-1500- Is this information wrong?
Education & Training
- Medical College of GeorgiaFellowship, Hematology and Medical Oncology, 1991 - 1992
- Medical College of GeorgiaResidency, Internal Medicine, 1990 - 1991
- Ankara University FOMClass of 1971
Certifications & Licensure
- GA State Medical License 1991 - 2025
Clinical Trials
- Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease Start of enrollment: 2010 Nov 01
Publications & Presentations
PubMed
- Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease.Marianne E M Yee, James W McCoy, Kirk A Easley, Clinton H Joiner, Janetta Bryksin, Christopher M Lough, Niren Patel, Cassandra D Josephson, Sean R Stowell, Ross M Fasa...> ;Transfusion. 2024 May 1
- Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi...Julie Kanter, Neha Bhasin, Stephanie Guarino, Patrick McGann, Sean R Stowell, Venée N Tubman, Cynthia Campos, Michael S Broder, Kenneth I Ataga, Abdullah Kutlar, Sophi...> ;Annals of Hematology. 2024 Apr 20
- 1 citationsMortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry.Franklin Njoku, Norma Pugh, Donald Brambilla, Barbara Kroner, Nirmish Shah, Marsha Treadwell, Robert Gibson, Lewis L Hsu, Victor R Gordeuk, Jeffrey Glassberg, Jane S H...> ;American Journal of Hematology. 2024 May 1
- Join now to see all
Abstracts/Posters
- Downregulation of Cytoskeletal Protein Kazrin in Lung Endothelial Cells of Preclinical Sickle Cell Disease Mouse Model - Essential Role of Endothelial Barrier FunctionAbdullah Kutlar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Crizanlizumab Treatment Is Associated with Clinically Significant Reductions in Hospitalization in Patients with Sickle Cell Disease: Results from the Sustain StudyAbdullah Kutlar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II StudiesAbdullah Kutlar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- Laboratory diagnosis of the hemoglobinopathiesKutlar A, Kutlar F
http://www.uptodate.com/contents/laboratory-diagnosis-of-the-hemoglobinopathies
UpToDate, Wolters Kluwer Health - 2012-03-13
Press Mentions
- New Drug Boosts Foetal Haemoglobin to Fight Sickle Cell DiseaseMay 18th, 2023
- Research Program Aimed at Diversity Brings Young Scientists to MCG Through July 30, 2019July 17th, 2019
- Novartis’ Crizanlizumab Relieves Patients from Sickle Cell Pain CrisisOctober 10th, 2018
- Join now to see all
Hospital Affiliations
- Charlie Norwood Veterans Affairs Medical CenterAugusta, Georgia
- WellStar MCG Health, affiliated with Medical College of GeorgiaAugusta, Georgia
- Phoebe Putney Memorial HospitalAlbany, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: